Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-3615


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 242, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
NIPA2 hsa-miR-3615 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:22851728-22851777 CLASH POSITIVE DIRECT TarBase 7.0
NUDT1 hsa-miR-3615 low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr7:2244680-2244704 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr7:2244680-2244704 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:2244680-2244704 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr7:2244680-2244704 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:2244680-2244704 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:2244680-2244704 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPIRE1 hsa-miR-3615 low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr18:12449420-12449448 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449420-12449448 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr18:12449420-12449448 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr18:12449420-12449448 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449420-12449448 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449420-12449448 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HNRNPM hsa-miR-3615 low: 0 high: 5 2 2 2 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:8488800-8488825 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:8488800-8488825 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:8485611-8485637 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:8483165-8483190 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:8483165-8483190 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARL8A hsa-miR-3615 low: 0 high: 5 1 1 1 0.544
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:202133608-202133631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:202133608-202133631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:202133608-202133631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:202133608-202133631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:202133608-202133631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MYD88 hsa-miR-3615 low: 0 high: 4 2 4 2 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr3:38142521-38142545 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:38142521-38142545 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:38142521-38142545 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:38142521-38142545 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SRRM2 hsa-miR-3615 low: 0 high: 4 1 1 1 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:2765849-2765869 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:2764752-2764778 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:2765849-2765869 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:2761861-2761885 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AP3D1 hsa-miR-3615 low: 0 high: 3 1 1 1 0.496
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:2112875-2112900 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:2112875-2112900 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:2112875-2112900 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RBM25 hsa-miR-3615 low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr14:73106040-73106061 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr14:73105898-73105922 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr14:73105885-73105909 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TSPAN3 hsa-miR-3615 low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr15:77052830-77052850 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr15:77052830-77052850 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr15:77052830-77052850 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DDX51 hsa-miR-3615 low: 0 high: 3 1 1 1 0.458
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:132137894-132137913 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:132137894-132137913 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:132137894-132137913 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TXLNA hsa-miR-3615 low: 0 high: 2 1 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:32197755-32197775 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:32197755-32197775 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDC23 hsa-miR-3615 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:138188623-138188639 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:138188623-138188639 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FBXL19 hsa-miR-3615 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:30928464-30928485 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr16:30924399-30924419 HITS-CLIP POSITIVE DIRECT TarBase 7.0
E2F3 hsa-miR-3615 low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:20402212-20402233 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:20402212-20402233 PAR-CLIP POSITIVE DIRECT TarBase 7.0
AHNAK hsa-miR-3615 low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:62516461-62516479 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62516461-62516479 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HNRNPA1 hsa-miR-3615 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr12:54286006-54286028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:54286006-54286028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TLE3 hsa-miR-3615 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr15:70097722-70097743 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr15:70064464-70064490 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TRIM65 hsa-miR-3615 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:75892838-75892865 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:75892838-75892865 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BTG2 hsa-miR-3615 low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:203307632-203307658 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:203307632-203307658 HITS-CLIP POSITIVE DIRECT TarBase 7.0